Skip to content

Clinical trials

Phase 2 Stomach Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 2 Country / region: United Kingdom Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20051
20061
20072
20101
20111
20123
20131
20141
20152
20172
20183
20194
20202
20221
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting7
Terminated4
Unknown status4
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Royal Marsden NHS Foundation Trust4
Amgen1
Apollomics Inc.1
BeiGene1
Bristol-Myers Squibb1
Cancer Advances Inc.1
Daiichi Sankyo1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms35
Esophageal Neoplasms10
Ovarian Neoplasms4
Adenocarcinoma3
Biliary Tract Neoplasms3
Breast Neoplasms3
Neoplasm Metastasis3
Pancreatic Neoplasms3
Triple Negative Breast Neoplasms3
Colorectal Neoplasms2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.